Dr Kin on Clinical Implications of the FDA Approval of Teclistamab in ...
OncLive - 23 May 2023Andrew Kin, MD, discusses clinical implications of the FDA approval for teclistamab-cqyv in relapsed/refractory multiple myeloma.
Multiple myeloma
Andrew Kin, MD, discusses clinical implications of the FDA approval for teclistamab-cqyv in relapsed/refractory multiple myeloma.
Daratumumab-based quadruplet therapy for transplant-eligible newly diagnosed multiple myeloma with high ...
Nature.com - 22 Apr 2024Daratumumab-based quadruplet therapy for transplant-eligible newly diagnosed multiple myeloma with high ... ...
Daratumumab Plus Standard Therapy for Multiple Myeloma
National Cancer Institute (.gov) - 19 Jan 2024Daratumumab Plus Standard Therapy for Multiple Myeloma ...
Dr Usmani on the Design of the CARTITUDE-4 Trial in Multiple Myeloma
OncLive - 24 Apr 2024Dr Usmani on the Design of the CARTITUDE-4 Trial in Multiple Myeloma ...
CAR T and Bispecifics Take Center Stage in New Myeloma Trials
Targeted Oncology - 22 Apr 2024CAR T and Bispecifics Take Center Stage in New Myeloma Trials ...
J&J reports $133M in sales for new multiple myeloma med Tecvayli
FiercePharma - 16 Apr 2024J&J reports $133M in sales for new multiple myeloma med Tecvayli ...
Types of Multiple Myeloma and Their Relative Outlooks
Healthline - 20 Mar 2024Types of Multiple Myeloma and Their Relative Outlooks ...
Study points to racial and social barriers that block treatment for multiple myeloma
Medical Xpress - 23 Apr 2024Study points to racial and social barriers that block treatment for multiple myeloma ...
Coffee and multiple myeloma: What is the link?
Medical News Today - 23 Feb 2024Coffee and multiple myeloma: What is the link? ...
FDA committee votes 12-0 for myeloma trial outcome measure –...
Myeloma Research News - 23 Apr 2024FDA committee votes 12-0 for myeloma trial outcome measure –... ...
Bispecific CAR T cell therapy targeting BCMA and CD19 in relapsed/refractory multiple myeloma: a phase I/II trial
Nature.com - 20 Apr 2024Bispecific CAR T cell therapy targeting BCMA and CD19 in relapsed/refractory multiple myeloma: a phase I/II trial ...
European Commission Approves Cilta-Cel for R/R Myeloma After at Least 1 Prior Line of Therapy
OncLive - 22 Apr 2024European Commission Approves Cilta-Cel for R/R Myeloma After at Least 1 Prior Line of Therapy ...
Richardson Discusses the Evolving Multiple Myeloma Treatment Landscape
Targeted Oncology - 19 Apr 2024Richardson Discusses the Evolving Multiple Myeloma Treatment Landscape ...
The enduring neutrophil–stroma dance of multiple myeloma
Nature.com - 10 Apr 2024The enduring neutrophil–stroma dance of multiple myeloma ...
Single-cell multiomic dissection of response and resistance to chimeric antigen receptor T cells against BCMA in ...
Nature.com - 19 Apr 2024Single-cell multiomic dissection of response and resistance to chimeric antigen receptor T cells against BCMA in ... ...
Rheological properties of blood in multiple myeloma patients | Scientific Reports
Nature.com - 21 Feb 2024Rheological properties of blood in multiple myeloma patients | Scientific Reports ...
The bone ecosystem facilitates multiple myeloma relapse and the evolution of heterogeneous drug resistant disease
Nature.com - 19 Mar 2024The bone ecosystem facilitates multiple myeloma relapse and the evolution of heterogeneous drug resistant disease ...
Large differencies in age-specific survival in multiple myeloma in the nordic countries | Blood Cancer Journal
Nature.com - 11 Mar 2024Large differencies in age-specific survival in multiple myeloma in the nordic countries | Blood Cancer Journal ...
In multiple myeloma, monthly treatment with zoledronic acid beyond two years offers sustained protection against ...
Nature.com - 15 Apr 2024In multiple myeloma, monthly treatment with zoledronic acid beyond two years offers sustained protection against ... ...
Prognostic factors in 448 newly diagnosed multiple myeloma receiving bortezomib-based induction: impact of ASCT ...
Nature.com - 21 Feb 2024Prognostic factors in 448 newly diagnosed multiple myeloma receiving bortezomib-based induction: impact of ASCT ... ...
What's New
- JEE Mains Result 2024 Live: Session 2 scorecard link, cut-offs ...
- Manchester United 4-2 Sheffield United (25 Apr, 2024) Game ...
- JEE Main Result 2024 Session 2 OUT: Check Direct Link to ...
- Everton vs Liverpool 2-0: Premier League football – as it happened
- JEE Main results 2024 declared, record 56 candidates get 100 NTA ...
- Why Rajinikanth, Kamal Haasan and other septuagenarians ...
- Rishabh Pant surpasses Shikhar Dhawan to become second ...
- Live blog - Pant, Axar, Kuldeep give Capitals tight win
- Priyanka Gandhi tears into Kerala CM, claims he's colluding with BJP
- MP Board Result 2024 LIVE Updates: Check Class 10th, 12th ...
- TS Inter Results 2024 Manabadi: Girls Outshine Boys with 62.14 ...
- Sudhir Kakar, the alchemist | Publisher David Davidar recalls his ...